Elevance Health Inc
NYSE:ELV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
394.2
560.6041
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Elevance Health Inc
Elevance Health Inc
Cash & Cash Equivalents
Elevance Health Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Elevance Health Inc
NYSE:ELV
|
Cash & Cash Equivalents
$7.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Cash & Cash Equivalents
$37.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
25%
|
CAGR 10-Years
18%
|
|
|
Centene Corp
NYSE:CNC
|
Cash & Cash Equivalents
$14.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
19%
|
CAGR 10-Years
25%
|
|
|
Molina Healthcare Inc
NYSE:MOH
|
Cash & Cash Equivalents
$4.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
|
Humana Inc
NYSE:HUM
|
Cash & Cash Equivalents
$5.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
|
|
Healthequity Inc
NASDAQ:HQY
|
Cash & Cash Equivalents
$326.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
32%
|
|
Elevance Health Inc
Glance View
Elevance Health Inc., formerly known as Anthem Inc., is a leading health benefits company that has made significant strides in transforming healthcare delivery in the United States. With a mission to improve lives and ensure access to healthcare, Elevance operates a diversified portfolio of health plans that cover millions of members across various states. The company has positioned itself as a key player in the healthcare ecosystem by leveraging technology and innovative solutions to enhance patient care, streamline operations, and optimize costs. As rising healthcare demands present both challenges and opportunities, Elevance is committed to creating value for its stakeholders through strategic investments and partnerships that expand its reach and capabilities. In recent years, Elevance has invested heavily in digital health solutions and personalized care programs, aimed at improving health outcomes while also tackling healthcare inefficiencies. These initiatives not only position the company as a competitive force in the marketplace but also align with the broader trend of value-based care, which rewards providers for quality over quantity. For investors, this adaptability and forward-thinking approach present a compelling opportunity as the company navigates the evolving landscape of healthcare. With strong financials backed by a diverse revenue base and a commitment to sustainability and community health initiatives, Elevance Health invites investors to join in the journey of transforming healthcare—one member at a time.
See Also
What is Elevance Health Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
7.9B
USD
Based on the financial report for Sep 30, 2024, Elevance Health Inc's Cash & Cash Equivalents amounts to 7.9B USD.
What is Elevance Health Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
16%
Over the last year, the Cash & Cash Equivalents growth was -28%. The average annual Cash & Cash Equivalents growth rates for Elevance Health Inc have been 13% over the past three years , 13% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
